{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:47:23Z","timestamp":1794707243118,"version":"4.9.1"},"reference-count":52,"publisher":"Bioscientifica","content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Type 1 pseudohypoaldosteronism (PHA) is a rare heterogeneous group of disorders characterised by resistance to aldosterone action. There is resultant salt wasting in the neonatal period, with hyperkalaemia and metabolic acidosis. Only after results confirm isolated resistance to aldosterone can the diagnosis of type 1 PHA be confidently made. Type 1 PHA can be further classified into i) renal type 1 (autosomal dominant (AD)) and ii) multiple target organ defect\/systemic type 1 (autosomal recessive (AR)). The aim of this case series was to characterise the mode of presentation, management and short-term clinical outcomes of patients with PHA type 1. Case notes of newly diagnosed infants presenting with PHA type 1 were reviewed over a 5-year time period. Seven patients were diagnosed with PHA type 1. Initial presentation ranged from 4 to 28 days of age. Six had weight loss as a presenting feature. All subjects had hyperkalaemia, hyponatraemia, with elevated renin and aldosterone levels. Five patients have renal PHA type 1 and two patients have systemic PHA type, of whom one has had genetic testing to confirm the AR gene mutation on the\n                    <jats:italic>SCNN1A<\/jats:italic>\n                    gene. Renal PHA type 1 responds well to salt supplementation, whereas management of patients with systemic PHA type 1 proves more difficult as they are likely to get frequent episodes of electrolyte imbalance requiring urgent correction.\n                  <\/jats:p>\n                  <jats:sec>\n                    <jats:title>Learning points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Patients with type 1 PHA are likely to present in the neonatal period with hyponatraemia, hyperkalaemia and metabolic acidosis and can be diagnosed by the significantly elevated plasma renin activity and aldosterone levels.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>The differential diagnosis of type 1 PHA includes adrenal disorders such as adrenal hypoplasia and congenital adrenal hyperplasia; thus, adrenal function including cortisol levels, 17-hydroxyprogesterone and a urinary steroid profile are required. Secondary (transient) causes of PHA may be due to urinary tract infections or renal anomalies; thus, urine culture and renal ultrasound scan are required respectively.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>A differentiation between renal and systemic PHA type 1 may be made based on sodium requirements, ease of management of electrolyte imbalance, sweat test results and genetic testing.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Management of renal PHA type 1 is with sodium supplementation, and requirements often decrease with age.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Systemic PHA type 1 requires aggressive and intensive fluid and electrolyte management. Securing an enteral feeding route and i.v. access are essential to facilitate ongoing therapy.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>In this area of the UK, the incidence of AD PHA and AR PHA was calculated to be 1:66\u200a000 and 1:166\u200a000 respectively.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/edm-13-0010","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T06:46:19Z","timestamp":1377845179000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":29,"title":["Pseudohypoaldosteronism type 1: clinical features and management in infancy"],"prefix":"10.1530","volume":"2013","author":[{"given":"N","family":"Amin","sequence":"first","affiliation":[{"name":"1 Paediatric Endocrinology, Leeds Teaching Hospitals, Leeds General Infirmary, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N S","family":"Alvi","sequence":"additional","affiliation":[{"name":"1 Paediatric Endocrinology, Leeds Teaching Hospitals, Leeds General Infirmary, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J H","family":"Barth","sequence":"additional","affiliation":[{"name":"2 Clinical Chemistry, Leeds Teaching Hospitals, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H P","family":"Field","sequence":"additional","affiliation":[{"name":"2 Clinical Chemistry, Leeds Teaching Hospitals, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Finlay","sequence":"additional","affiliation":[{"name":"3 Paediatric Nephrology, Leeds Teaching Hospitals, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tyerman","sequence":"additional","affiliation":[{"name":"3 Paediatric Nephrology, Leeds Teaching Hospitals, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Frazer","sequence":"additional","affiliation":[{"name":"4 Paediatric Medicine, Bradford Teaching Hospitals, Bradford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Savill","sequence":"additional","affiliation":[{"name":"5 Paediatric Medicine, Airedale General Hospital, Keighley, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N P","family":"Wright","sequence":"additional","affiliation":[{"name":"6 Paediatric Endocrinology, Sheffield Children's Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Makaya","sequence":"additional","affiliation":[{"name":"6 Paediatric Endocrinology, Sheffield Children's Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Mushtaq","sequence":"additional","affiliation":[{"name":"1 Paediatric Endocrinology, Leeds Teaching Hospitals, Leeds General Infirmary, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref451","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/01.ASN.0000028641.59030.B2","article-title":"Disturbances of Na\/K balance: pseudohypoaldosteronism revisited","volume":"13","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/adc.57.9.718","article-title":"Pseudohypoaldosteronism. Response to long term treatment with indomethacin","volume":"57","year":"1982","journal-title":"Archives of Disease in Childhood"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00540254","article-title":"Pseudohypoaldosteronism in a child with Down syndrome. Long term management of salt loss by ion exchange resin administration","volume":"142","year":"1984","journal-title":"European Journal of Pediatrics"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/ndt\/gfm862","article-title":"Pseudohypoaldosteronisms, report on a 10-patient series","volume":"23","year":"2008","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"ref511","first-page":"76","article-title":"Congenital pseudohypoaldosteronism presenting in utero with acute polyhydramnios","volume":"7","year":"1998","journal-title":"Journal of Maternal\u2013Fetal Medicine"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM199907153410304","article-title":"Pulmonary epithelial sodium channel dysfunction and excess airway liquid in pseudohypoaldosteronism","volume":"341","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0022-3476(06)80176-9","article-title":"Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis","volume":"125","year":"1994","journal-title":"Journal of Pediatrics"},{"key":"ref341","first-page":"484","article-title":"Sweat glands in pseudohypoaldosteronism","volume":"38","year":"1978","journal-title":"Der Hautarzt; Zeitschrift f\u00fcr Dermatologie, Venerologie, und verwandte Gebiete"},{"key":"ref201","first-page":"1133","article-title":"Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore","volume":"47","year":"1995","journal-title":"Molecular Pharmacology"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.physiol.010908.163250","article-title":"The contribution of epithelial sodium channels to alveolar function in health and disease","volume":"71","year":"2009","journal-title":"Annual Review of Physiology"},{"key":"ref81","first-page":"484","article-title":"Sweat glands in pseudohypoaldosteronism","volume":"38","year":"1978","journal-title":"Der Hautarzt; Zeitschrift f\u00fcr Dermatologie, Venerologie, und verwandte Gebiete"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ng0396-248","article-title":"Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type I","volume":"12","year":"1996","journal-title":"Nature Genetics"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1073\/pnas.051603198","article-title":"Transcriptome of a mouse kidney cortical collecting duct cell line: effects of aldosterone and vasopressin","volume":"98","journal-title":"PNAS"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1097\/01.ASN.0000028641.59030.B2","article-title":"Disturbances of Na\/K balance: pseudohypoaldosteronism revisited","volume":"13","year":"2002","journal-title":"Journal of the American Society of Nephrology"},{"key":"ref331","first-page":"27","article-title":"Long-term outcome of autosomal recessive pseudohypoaldosteronism","volume":"17","year":"2008","journal-title":"Endocrine Abstracts"},{"key":"ref71","first-page":"27","article-title":"Long-term outcome of autosomal recessive pseudohypoaldosteronism","volume":"17","year":"2008","journal-title":"Endocrine Abstracts"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/adc.33.169.252","article-title":"A salt wasting syndrome in infancy","volume":"33","year":"1958","journal-title":"Archives of Disease in Childhood"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/adc.57.9.718","article-title":"Pseudohypoaldosteronism. Response to long term treatment with indomethacin","volume":"57","year":"1982","journal-title":"Archives of Disease in Childhood"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s004310050615","article-title":"Pseudohypo-aldosteronism and cholelithiasis: coincidence or pathogenetic correlation?","volume":"156","year":"1997","journal-title":"European Journal of Pediatrics"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/adc.33.169.252","article-title":"A salt wasting syndrome in infancy","volume":"33","year":"1958","journal-title":"Archives of Disease in Childhood"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/adc.55.6.427","article-title":"Pseudohypoaldosteronism","volume":"55","year":"1980","journal-title":"Archives of Disease in Childhood"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1210\/jc.2006-1161","article-title":"Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1","volume":"91","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref261","first-page":"1429","article-title":"Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults","volume":"17","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ng0696-248","article-title":"A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families","volume":"13","year":"1996","journal-title":"Nature Genetics"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1073\/pnas.051603198","article-title":"Transcriptome of a mouse kidney cortical collecting duct cell line: effects of aldosterone and vasopressin","volume":"98","journal-title":"PNAS"},{"key":"ref01","first-page":"1429","article-title":"Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults","volume":"17","year":"2000","journal-title":"Journal of the American Society of Nephrology"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF00540254","article-title":"Pseudohypoaldosteronism in a child with Down syndrome. Long term management of salt loss by ion exchange resin administration","volume":"142","year":"1984","journal-title":"European Journal of Pediatrics"},{"key":"ref131","first-page":"81","article-title":"Renal prostaglandins and the regulation of blood pressure and sodium and water homeostasis","volume":"121","year":"1976","journal-title":"American Journal of Medicine"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM199907153410304","article-title":"Pulmonary epithelial sodium channel dysfunction and excess airway liquid in pseudohypoaldosteronism","volume":"341","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/adc.55.6.427","article-title":"Pseudohypoaldosteronism","volume":"55","year":"1980","journal-title":"Archives of Disease in Childhood"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1210\/jc.2006-1161","article-title":"Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1","volume":"91","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/adc.88.12.1138-b","article-title":"The use of sodium resonium in pseudohypoaldosteronism","volume":"88","year":"2003","journal-title":"Archives of Disease in Childhood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0039-128X(94)00034-A","article-title":"Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism","volume":"60","year":"1995","journal-title":"Steroids"},{"key":"ref161","first-page":"1441","article-title":"Control of sodium transport by aldosterone","volume-title":"The Kidney, Physiology and Physiopathology","year":"2001"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ng0696-248","article-title":"A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families","volume":"13","year":"1996","journal-title":"Nature Genetics"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s004310050615","article-title":"Pseudohypo-aldosteronism and cholelithiasis: coincidence or pathogenetic correlation?","volume":"156","year":"1997","journal-title":"European Journal of Pediatrics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/ndt\/gfm862","article-title":"Pseudohypoaldosteronisms, report on a 10-patient series","volume":"23","year":"2008","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.physiol.010908.163250","article-title":"The contribution of epithelial sodium channels to alveolar function in health and disease","volume":"71","year":"2009","journal-title":"Annual Review of Physiology"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ng0396-248","article-title":"Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type I","volume":"12","year":"1996","journal-title":"Nature Genetics"},{"key":"ref421","first-page":"1441","article-title":"Control of sodium transport by aldosterone","volume-title":"The Kidney, Physiology and Physiopathology","year":"2001"},{"key":"ref461","first-page":"1133","article-title":"Alternatively spliced forms of the alpha subunit of the epithelial sodium channel: distinct sites for amiloride binding and channel pore","volume":"47","year":"1995","journal-title":"Molecular Pharmacology"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/adc.88.12.1138-b","article-title":"The use of sodium resonium in pseudohypoaldosteronism","volume":"88","year":"2003","journal-title":"Archives of Disease in Childhood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000224334","article-title":"Clinical and molecular features of type 1 pseudohypoaldosteronism","volume":"72","year":"2009","journal-title":"Hormone Research"},{"key":"ref251","first-page":"76","article-title":"Congenital pseudohypoaldosteronism presenting in utero with acute polyhydramnios","volume":"7","year":"1998","journal-title":"Journal of Maternal\u2013Fetal Medicine"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0022-3476(06)80176-9","article-title":"Pseudohypoaldosteronism with increased sweat and saliva electrolyte values and frequent lower respiratory tract infections mimicking cystic fibrosis","volume":"125","year":"1994","journal-title":"Journal of Pediatrics"},{"key":"ref401","first-page":"153","article-title":"Congenital pseudohypoaldosteronism: case report and review. Effect of indomethacin during sodium chloride depletion","volume":"33","year":"1978","journal-title":"Helvetica Paediatrica Acta"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1074\/jbc.M312477200","article-title":"Relative contribution of Nedd4 and Nedd4-2 to ENaC regulation in epithelia determined by RNA interference","volume":"279","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0039-128X(94)00034-A","article-title":"Molecular characterization of the mineralocorticoid receptor in pseudohypoaldosteronism","volume":"60","year":"1995","journal-title":"Steroids"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1074\/jbc.M312477200","article-title":"Relative contribution of Nedd4 and Nedd4-2 to ENaC regulation in epithelia determined by RNA interference","volume":"279","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"ref391","first-page":"81","article-title":"Renal prostaglandins and the regulation of blood pressure and sodium and water homeostasis","volume":"121","year":"1976","journal-title":"American Journal of Medicine"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000224334","article-title":"Clinical and molecular features of type 1 pseudohypoaldosteronism","volume":"72","year":"2009","journal-title":"Hormone Research"},{"key":"ref141","first-page":"153","article-title":"Congenital pseudohypoaldosteronism: case report and review. Effect of indomethacin during sodium chloride depletion","volume":"33","year":"1978","journal-title":"Helvetica Paediatrica Acta"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2013\/1\/EDM13-0010.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2013\/1\/EDM13-0010.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:45:47Z","timestamp":1784555147000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,1]]},"references-count":52,"URL":"https:\/\/doi.org\/10.1530\/edm-13-0010","relation":{},"ISSN":["2052-0573","2052-0573"],"issn-type":[{"value":"2052-0573","type":"print"},{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,1]]}}}